Empagliflozin increases QoL and overall survival in adults with acute heart failure: AHA MD Editorial Team15 Nov 2021 7:46 PM ISTAccording to late-breaking research presented at the American Heart Association's Scientific Sessions 2021 on 14th November 2021, adults treated with...
Ursolic acid and empagliflozin combo better for treating diabetic nephropathy, study finds Medha Baranwal11 Nov 2021 9:00 AM ISTChina: A recent study in the journal Biomedicine & Pharmacotherapy has shown that a combination of ursolic acid (UA) and empagliflozin (EM) is...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Roshni Dhar1 Nov 2021 11:24 AM ISTIn a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 29/October/2021 Roshni Dhar30 Oct 2021 11:09 AM ISTHere are Top Health Stories of the dayMadras HC slams Medical Council for removing gastroenterologist's name, gives 14 pointer guidelinesSlamming the...
RYGB reduces microalbuminuria and A1c better than empagliflozin and liraglutide: Study Dr. Shravani Dali28 Oct 2021 10:00 AM ISTIndividuals who receive Roux-en-Y Gastric Bypass have a greater reduction in microalbuminuria and A1c compared with those treated with empagliflozin...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Medical Dialogues Team27 Oct 2021 1:21 PM ISTNew Delhi: In a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
Health Bulletin 25/October/2021 Roshni Dhar25 Oct 2021 4:23 PM ISTHere are Top Health Stories of the dayDoctors cannot function under threat of being harassed, beaten up: High CourtThe Punjab and Haryana High Court...
Empagliflozin reduces insulin initiation in patients with diabetes and CVD: EMPA-REG OUTCOME trial Medha Baranwal25 Oct 2021 9:30 AM ISTUSA: Empagliflozin markedly and durably delays insulin initiation and substantial increases in insulin dose in patients with type 2 diabetes and...
Dr Reddys, MSN Labs launch of generic Empagliflozin may lead to court battle Farhat Nasim20 Oct 2021 2:01 PM ISTHyderabad: Taking head-on collision with Boehringer Ingelheim over blockbuster diabetes drug, two Indian pharma giants have recently launched their...
Empagliflozin reduces cardiac and renal risk in HFrEF patients, regardless of baseline NT-proBNP: Study Medha Baranwal9 Oct 2021 10:08 AM ISTUSA: Findings from the EMPEROR-Reduced trial showed higher baseline NT-proBNP concentrations to be associated with poor cardiorenal outcomes. However,...
Empagliflozin markedly improves BMI, blood sugar, BP in diabetics: SUPER GATE study Medha Baranwal18 Sept 2021 9:00 AM ISTBolu, Turkey: Empagliflozin add-on treatment improved metabolic parameters, blood pressure, and anthropometric measures and did not deteriorate kidney...
Empagliflozin significantly reduces hospitalization risk in patients of HFpEF, shows trial Dr. Kamal Kant Kohli30 Aug 2021 6:00 AM ISTFrance: SGLT-2 inhibitor, Empagliflozin significantly reduced heart failure-related hospitalizations, regardless of patient diabetes status, reveal...
